Mammography Market – Overview
In
2022, the mammography market was valued at USD 2.5 billion. The mammography
industry is expected to expand from USD 2.73 billion in 2023 to USD 5.54
billion by 2032, with a compound annual growth rate (CAGR) of 9.25% over the
forecast period (2023-2032).
The diagnostic mammogram
market offers vital insights into breast health, aiding in early
detection of abnormalities. With advancements in technology, such as digital
mammography, the market continues to grow. Screening programs and awareness
initiatives further drive demand. This market plays a crucial role in women's
healthcare, promoting early intervention and improved outcomes.
The
mammography market is anticipated to expand due to factors such as an increase
in the number of breast cancer cases, more female awareness, technological
innovations, and an increase in the number of government programs. Rising
healthcare costs, a burgeoning healthcare industry, and a growing desire for
more frequent monitoring are just a few of the primary factors expected to
drive mammography machine demand in the coming years.
Competitive Analysis
The
contemporary landscape drives end-to-end transformation, from the rapid
adoption of new working practices to the incubation of new business models.
Players will benefit from seeking out new collaborations and curating value
ecosystems to move faster while developing new products and services that meet
customer expectations. Customer expectations and experiences are being
transformed by technology, and it's occurring quicker than ever before. Leaders
play a critical role in implementing modern technology and data to combine
processes that meet evolving needs as digital acceleration transforms
industries and customer and employee expectations. The COVID-19 outbreak is
still changing the world as we know it, particularly in terms of how we behave
and interact as organizations and as individuals. Some industries are expected
to rebound faster than others, reflecting shifts in consumer behavior. The
pandemic has sparked change, typically in the area of digital transformation,
and a variety of projects ranging from virtual sales and service to e-commerce
to data acceleration are not only swiftly becoming a new directive but are also
becoming a new standard.
The mammography key players are
Siemens Healthcare GmbH (Germany), Shimadzu Corporation (Japan), FUJIFILM
Holdings Corporation (Japan), General Electric Company (U.S.), Koninklijke
Philips (Netherland), Carestream Health, Inc. (U.S.), Hitachi Medical
Corporation (Japan), Toshiba Medical Systems Corporation (Japan), and Hologic,
Inc (U.S.).
Segment Analysis
The
segmentation of the mammography market is conducted based on type, treatment,
end user, and region. The type segment of the mammography market consists of
diagnostic mammograms and screening mammograms. The region segment of the
mammography market consists of Europe, Asia-Pacific, Americas, and Middle East
& Africa. The treatment segment of the mammography market consists of
digital systems, film-screen systems, breast tomosynthesis, and analog systems.
The end-user segment of the mammography market consists of hospitals,
diagnostic centers, research institutes, and specialty clinics.
Regional Analysis
The
regional assessment of the mammography market includes regions such as the
Americas, Europe, Asia-Pacific, and the Middle East, and Africa. The mammography market in
the Americas is expected to dominate the global industry due to the rising
incidence of breast cancer and rising per capita healthcare spending in the
region. The European market is rapidly developing. This is attributable to the
presence of a well-established healthcare system and increased government
incentives to develop innovative treatment options, and the mammography market
share is predicted to grow rapidly. Breast cancer surgeries and medicines, for
example, have become more efficient since the advent of next-generation 3D
mammography technology.
